Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“ESMO TAT Asia26 in full swing in HongKong.
Excellent science being discussed, but even more importantly wonderful connections being made.”
Other articles about ESMO TAT Asia26 on OncoDaily.
